Medtronic (MDT) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

MDT Stock Forecast


Medtronic (MDT) stock forecast, based on 51 Wall Street analysts, predicts a 12-month average price target of $99.40, with a high of $119.00 and a low of $83.00. This represents a 7.83% increase from the last price of $92.18.

$75 $84 $93 $102 $111 $120 High: $119 Avg: $99.4 Low: $83 Last Closed Price: $92.18

MDT Stock Rating


Medtronic stock's rating consensus is Buy, based on 51 Wall Street analysts. The breakdown includes 1 Strong Buy (1.96%), 30 Buy (58.82%), 20 Hold (39.22%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 51 20 30 1 Strong Sell Sell Hold Buy Strong Buy

MDT Price Target Upside V Benchmarks


TypeNameUpside
StockMedtronic7.83%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks16.07%

Price Target Trends


1M3M12M
# Anlaysts82146
Avg Price Target$103.63$95.48$102.48
Last Closing Price$92.18$92.18$92.18
Upside/Downside12.42%3.58%11.17%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 263179--29
Aug, 2631610--29
Jul, 2631512--30
Jun, 2621513--30
May, 2641411--29
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 03, 2026Deutsche Bank$92.00$91.510.54%-0.20%
Sep 03, 2026UBS$110.00$92.1819.33%19.33%
Sep 02, 2026Anthony PetroneMizuho Securities$115.00$92.1824.76%24.76%
Sep 02, 2026Rick WiseStifel Nicolaus$95.00$92.043.22%3.06%
Sep 02, 2026Larry BiegelsenWells Fargo$104.00$92.0412.99%12.82%
Sep 02, 2026Richard NewitterTruist Financial$99.00$92.047.56%7.40%
Sep 01, 2026BTIG$100.00$92.448.18%8.48%
Aug 27, 2026Needham$114.00$92.0223.89%23.67%
Jul 28, 2026Priya SachdevaUBS$100.00$84.2218.74%8.48%
Jul 13, 2026Ryan ZimmermanBTIG$91.00$83.878.50%-1.28%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Sep 03, 2026Deutsche BankHoldHoldhold
Sep 03, 2026UBSBuyBuyhold
Sep 02, 2026Bank of America SecuritiesBuyBuyhold
Sep 02, 2026Wells FargoOverweightOverweighthold
Sep 01, 2026BTIGBuyBuyhold
Aug 28, 2026Cowen & Co.BuyBuyhold
Aug 27, 2026NeedhamBuyBuyhold
Aug 10, 2026Piper SandlerNeutralNeutralhold
Aug 10, 2026Bank of America SecuritiesBuyBuyhold
Jul 28, 2026UBSNeutralBuyupgrade

Financial Forecast


EPS Forecast

$2 $3 $4 $5 $6 $7 $8 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$3.75$2.83$2.77$3.63$3.75---
Avg Forecast$5.66$5.27$5.20$5.45$5.84$6.30$6.85$7.36
High Forecast$5.72$5.33$5.23$5.47$5.88$6.65$6.92$7.44
Low Forecast$5.60$5.22$5.19$5.44$5.76$4.95$6.78$7.29
Surprise %-33.75%-46.30%-46.73%-33.39%-35.79%---

Revenue Forecast

$30B $33B $36B $39B $42B $45B Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$31.69B$31.23B$32.36B$33.54B$36.36B---
Avg Forecast$32.02B$30.94B$32.22B$33.57B$35.14B$36.89B$39.10B$41.02B
High Forecast$32.28B$31.25B$32.26B$33.65B$35.36B$36.91B$39.42B$41.35B
Low Forecast$31.76B$30.63B$32.16B$33.47B$34.94B$36.88B$38.79B$40.70B
Surprise %-1.05%0.94%0.44%-0.11%3.47%---

Net Income Forecast

$3B $4B $6B $7B $9B $10B Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$5.04B$3.76B$3.68B$4.66B$4.80B---
Avg Forecast$4.39B$7.02B$4.29B$7.26B$7.74B$7.72B$9.11B$9.79B
High Forecast$5.27B$7.09B$5.15B$7.28B$7.82B$8.85B$9.21B$9.90B
Low Forecast$3.51B$6.94B$3.43B$7.24B$7.66B$6.58B$9.02B$9.70B
Surprise %14.78%-46.43%-14.27%-35.77%-38.02%---

MDT Forecast FAQ


Is Medtronic stock a buy?

Medtronic stock has a consensus rating of Buy, based on 51 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 30 Buy, 20 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Medtronic is a favorable investment for most analysts.

What is Medtronic's price target?

Medtronic's price target, set by 51 Wall Street analysts, averages $99.4 over the next 12 months. The price target range spans from $83 at the low end to $119 at the high end, suggesting a potential 7.83% change from the previous closing price of $92.18.

How does Medtronic stock forecast compare to its benchmarks?

Medtronic's stock forecast shows a 7.83% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (16.07%).

What is the breakdown of analyst ratings for Medtronic over the past three months?

  • September 2026: 10.34% Strong Buy, 58.62% Buy, 31.03% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 10.34% Strong Buy, 55.17% Buy, 34.48% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 10.00% Strong Buy, 50.00% Buy, 40.00% Hold, 0% Sell, 0% Strong Sell.

What is Medtronic’s EPS forecast?

Medtronic's average annual EPS forecast for its fiscal year ending in April 2027 is $6.3, marking a 68.00% increase from the reported $3.75 in 2026. Estimates for the following years are $6.85 in 2028, and $7.36 in 2029.

What is Medtronic’s revenue forecast?

Medtronic's average annual revenue forecast for its fiscal year ending in April 2027 is $36.89B, reflecting a 1.45% increase from the reported $36.36B in 2026. The forecast for 2028 is $39.1B, and $41.02B for 2029.

What is Medtronic’s net income forecast?

Medtronic's net income forecast for the fiscal year ending in April 2027 stands at $7.72B, representing an 60.74% increase from the reported $4.8B in 2026. Projections indicate $9.11B in 2028, and $9.79B in 2029.